Michelle Divelbiss is an attorney in Axinn, Veltrop & Harkrider LLP’s Intellectual Property and Food and Drug Administration practice groups. Her practice involves patent litigation, particularly cases brought under the Hatch-Waxman Act, and counseling relating to FDA matters.